文章摘要
王威,程倩倩,周雪丽,等.肝细胞癌免疫相关基因和 lncRNA联合预后模型的构建及验证[J].安徽医药,2024,28(4):789-793.
肝细胞癌免疫相关基因和 lncRNA联合预后模型的构建及验证
Construction and validation of a combined prognostic model of immune-related genes and lncRNAs in hepatocellular carcinoma
  
DOI:10.3969/j.issn.1009-6469.2024.04.033
中文关键词: 癌,肝细胞  免疫相关基因  lncRNA  预后模型
英文关键词: Carcinoma, hepatocellular  Immune-related genes  LncRNA  Prognostic model
基金项目:安徽省高校优秀青年人才支持计划项目( gxyq2022042);蚌埠医学院 “512人才培育计划”(by51202208);蚌埠医学院第一附属医院杰出青年科学基金( 2019byyfyjq02)
作者单位E-mail
王威 蚌埠医学院第一附属医院肿瘤内科安徽蚌埠 233004  
程倩倩 蚌埠医学院第一附属医院肿瘤内科安徽蚌埠 233004  
周雪丽 蚌埠医学院第一附属医院肿瘤内科安徽蚌埠 233004  
季文斌 蚌埠医学院第一附属医院肿瘤内科安徽蚌埠 233004  
吕振宇 蚌埠医学院第一附属医院肿瘤内科安徽蚌埠 233004  
杨燕 蚌埠医学院第一附属医院肿瘤内科安徽蚌埠 233004 qiannianhupo@163.com 
摘要点击次数: 219
全文下载次数: 132
中文摘要:
      目的构建肝细胞癌(HCC)免疫相关的基因( IRGs)和 lncRNA(IRlncRNAs)联合预后模型。方法 2022年 6—8月通过 TCGA数据库下载 HCC转录组及临床数据;对转录组中 IRGs进行加权基因共表达网络分析( WGCNA)得到与预后相关的核心基因,对核心基因与转录组中 lncRNA共表达分析得到 IRlncRNAs;单因素 Cox回归筛选生存相关的 IRGs和 IRlncRNAs,LASSO回归构建模型并进行验证;对高低风险病人差异表达的基因进行 GO(基因本体论)和 KEGG(京都基因与基因组百科全书)分析探索影响预后的可能机制。结果构建了由 6个 IRGs及 7个 IRlncRNAs组成的预后风险模型;不同风险病人组织学分级(P =0.001)、临床分期(P=0.005)、 T分期( P=0.010)差异有统计学意义;在训练集、测试集和总样本集中,高风险病人总生存期较低风险病人显著降低(均 P<0.05);模型在预测 HCC病人 1年生存率中表现良好,训练集、测试集和总样本集受试者操作特征(ROC)曲线下面积分别为 0.85、0.81和 0.83;多因素 Cox回归表明评分可独立于其他特征预测病人生存( P<0.001); GO分析显示差异基因主要参与有丝分裂等事件; KEGG分析显示差异基因参与了磷脂酰肌醇 3激酶 -蛋白激酶 B、细胞周期等通路。结论基于 IRGs和 IRlncRNAs构建的 HCC预后模型具有较好的预测价值,可能有助于 HCC的临床决策和管理。
英文摘要:
      Objective To construct a combined prognostic model of immune-related genes (IRGs) and lncRNAs (IRlncRNAs) in he? patocellular carcinoma (HCC).Methods From June to August 2022, HCC transcriptome and clinical data from the Cancer Genome At?las (TCGA) database were downloaded. The weighted gene co-expression network analysis (WGCNA) of IRGs in the transcriptome wasperformed to obtain the core genes related to prognosis, and the co-expression analysis of core genes and IRlncRNAs in the transcrip?tome was performed to obtain IRlncRNAs. Univariate Cox regression analysis was used to screen survival-related IRGs and IRln? cRNAs, and LASSO regression was used to construct the combined risk model and the model was validated. Gene Ontology (GO) en?richment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway analysis of differentially expressed genesbetween high and low risk patients were performed to explore the possible mechanism affecting prognosis.Results A prognostic modelconsisting of 6 IRGs and 7 IRlncRNAs was constructed. There were significant differences in histological grade classification (P= 0.001), clinical stage (P=0.005), and T stage (P=0.010) among patients with different risks. The overall survival time of high-risk group was significantly reduced compared with that of low-risk group in train set, test set and total sample set (all P<0.05). The model per? formed well in predicting 1-year survival rate of HCC patients, and the areas under the ROC curve (AUC) in train set, test set, and totalsample set were 0.85, 0.81, and 0.83, respectively. Multivariate Cox regression showed that the score could predict patient survival in?dependently of other characteristics to predict patient survival (P<0.001). GO analysis showed that differential genes were mainly in?volved in mitosis and other events. KEGG analysis showed that differential genes were involved in PI3K-AKT, cell cycle and other path? ways.Conclusion The HCC prognostic model constructed based on IRGs and IRlncRNAs has a good predictive value and may helpin HCC clinical decision-making and management.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮